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ABSTRACT 
According to Article 12 of Regulation (EC) No 396/2005, the European Food Safety Authority (EFSA) has 
reviewed the Maximum Residue Levels (MRLs) currently established at European level for the pesticide active 
substance quinoclamine. Considering that this active substance is not authorised for use on edible crops within 
the European Union, that no MRLs are established by the Codex Alimentarius Commission, and that no import 
tolerances were notified to EFSA, residues of quinoclamine are not expected to occur in any plant or animal 
commodity. Available data were also not sufficient to derive a residue definition or an LOQ for enforcement 
against potential illegal uses. 
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SUMMARY 
Quinoclamine was included in Annex I to Directive 91/414/EEC on 01 January 2009, which is after 
the  entry  into  force  of Regulation (EC) No 396/2005 on 02 September 2008. EFSA is therefore 
required to provide a reasoned opinion on the review of the existing MRLs for that active substance in 
compliance with Article 12(1) of afore mentioned regulation. In order to collect the relevant pesticide 
residues data, EFSA asked Sweden, as the designated rapporteur Member State (RMS), to complete 
the Pesticide Residues Overview File (PROFile) and to prepare a supporting evaluation report. An 
evaluation report was submitted on 31 March 2010 confirming that the pesticide use of quinoclamine 
is only intended on non-consumable crops within the European Union (turf, lawn, ornamentals and 
nursery stock plants) and that no import tolerances for this active substance were notified to the RMS. 
Submission  of  a  PROFile  was  therefore  not  considered  relevant  and  EFSA  based  its  assessment 
mainly on the conclusions derived by EFSA in the framework of Directive 91/414/EEC. 
On 18 December 2012, EFSA issued a draft reasoned opinion that was circulated to Member State 
experts  for  consultation.  No  comments  were  received  by  22  February  2013  and  the  following 
conclusions are derived. 
The toxicological profile of quinoclamine was evaluated in the framework of Directive 91/414/EEC, 
which resulted in an ADI and an ARfD being established at 0.002 mg/kg bw per d and 0.05 mg/kg bw, 
respectively.  
Considering that the use of quinoclamine is restricted to non-consumable crops within the European 
Union, that no CXLs are available for this active substance and that no  uses authorised in third 
countries were notified to the RMS, residues of quinoclamine are not expected to occur in any plant 
or  animal  product.  However,  this  conclusion  is  only  valid  if  Member  States  impose  adequate 
restrictions on the conversion of treated  turf, lawn, ornamental fields or nurseries to edible plant 
production. 
Even though there are indications that the relevant residue following a foliar application in grass is the 
parent  compound  only,  EFSA  is  however  not  in  a  position  to  define  the  relevant  residue  for 
enforcement against the potential illegal use of quinoclamine. Validated analytical methods are also 
not available. 
A risk assessment is in principle not required considering that quinoclamine is only registered for use 
on non-consumable crops and that no import tolerances have been notified but the default MRL of 
0.01 mg/kg, as defined by Regulation (EC) No 396/2005, provides a satisfactory level of protection 
for the European consumer. 
Considering that the enforcement of potential illegal uses falls under the remit of risk managers, 
EFSA is not in a position to recommend whether the default MRL of 0.01 mg/kg, as defined by 
regulation (EC) No 396/2005, should apply or whether the setting of a specific LOQ is necessary. 
However, data for deriving a specific LOQ are very limited and quinoclamine is in any case not 
recommended for inclusion in Annex IV to the above regulation.  
 
 Review of the existing MRLs for quinoclamine 
 
EFSA Journal 2013;11(3):3141  3 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 3 
Background .............................................................................................................................................. 3 
Terms of reference ................................................................................................................................... 4 
The active substance and its use pattern .................................................................................................. 4 
Assessment ............................................................................................................................................... 5 
1.  Methods of analysis ......................................................................................................................... 5 
2.  Mammalian toxicology .................................................................................................................... 5 
3.  Residues  ........................................................................................................................................... 6 
4.  Consumer risk assessment ............................................................................................................... 7 
Conclusions and recommendations .......................................................................................................... 7 
References ................................................................................................................................................ 7 
Appendix – Pesticide Residues Intake Model (PRIMo) .......................................................................... 9 
Abbreviations ......................................................................................................................................... 11 
BACKGROUND 
Regulation (EC) No 396/2005
4 establishes the rules governing the setting as well as the review of 
pesticide MRLs at European level. Article 12(1) of that regulation lays down that EFSA shall provide 
within 12 months from the date of the inclusion or non-inclusion of an active substance in Annex I to 
Directive 91/414/EEC
5  a reasoned opinion on the review of the existing MRLs for  that active 
substance. As quinoclamine was included in Annex I to the above mentioned Directive on 01 January 
2009, EFSA initiated the review of all existing MRLs for that active substance and a task with the 
reference number EFSA-Q-2009-00114 was included in the EFSA Register of Questions. 
According to the legal provisions, EFSA shall base its rea soned opinion in particular on the relevant 
assessment report prepared under Directive 91/414/EEC. It should be noted, however, that in the 
framework of Directive 91/414/EEC only a few representative uses are evaluated while MRLs set out 
in Regulation (EC) No 396/2005 should accommodate for all uses authorised within the EU as well as 
uses authorised in third countries having a significant impact on international trade. The information 
included in the assessment report prepared under Directive 91/414/EEC is  therefore insufficient for 
the assessment of all existing MRLs for a given active substance. 
In order to gain an overview of the pesticide residues data that have been considered for the setting of 
the existing MRLs, EFSA developed the Pesticide Residue s Overview File (PROFile). The PROFile 
is an electronic inventory of all pesticide residues data relevant to the risk assessment as well as the 
MRL setting for a given active substance. This includes data on: 
  the nature and magnitude of residues in primary crops; 
  the nature and magnitude of residues in processed commodities;  
  the nature and magnitude of residues in rotational crops;  
  the nature and magnitude of residues in livestock commodities and;  
  the analytical methods for enforcement of the proposed MRLs. 
                                                       
4 Commission Regulation (EC) No 396/2005 of 23 February 2005. OJ L 70, 16.3.2005, p. 1-16. 
5 Council Directive 91/414/EEC of 15 July 1991, OJ L 230, 19.8.1991, p. 1-32. Review of the existing MRLs for quinoclamine 
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Sweden, the designated rapporteur Member State (RMS) in the framework of Directive 91/414/EEC, 
was asked to complete the PROFile for quinoclamine and to prepare a supporting evaluation report. 
An  evaluation  report  was  submitted  on  31  March  2010  confirming  that  the  pesticide  use  of 
quinoclamine  is  only  intended  on  non-consumable  crops  within  the  European  Union  (turf,  lawn, 
ornamentals and nursery stock plants) and that no import tolerances for this active substance were 
notified to the RMS. Submission of a PROFile was therefore not considered relevant.  
A draft reasoned opinion was issued by EFSA on 18 December 2012 and submitted to Member States 
(MS) for commenting. No comments were received by 22 February 2013. 
TERMS OF REFERENCE 
According to Article 12 of Regulation (EC) No 396/2005, EFSA shall provide a reasoned opinion on: 
  the inclusion of the active substance in Annex IV to the Regulation, when appropriate; 
  the necessity of setting new MRLs for the active substance or deleting/modifying existing MRLs 
set out in Annex II or III of the Regulation; 
  the inclusion of the recommended MRLs in Annex II or III to the Regulation; 
  the setting of specific processing factors as referred to in Article 20(2) of the Regulation. 
THE ACTIVE SUBSTANCE AND ITS USE PATTERN 
Quinoclamine is the ISO common name for 2-amino-3-chloro-1,4-naphthoquinone (IUPAC). 
O
O
NH2
Cl
 
Quinoclamine  belongs  to  the  group  of  quinone  compounds  which  are  used  as  herbicide  and/or 
algaecide. Quinoclamine is taken up by the aerial plant parts of mosses upon contact, while transport 
inside the plant is limited. It may also be taken up by the roots of plants. Quinoclamine belongs to the 
chemical  class  of  quinones,  which  occur  naturally  in  many  plants  and  are  also  produced  upon 
oxidation of plant phenolic compounds. The mode of action is by binding to a protein involved in 
electron transfer in photosynthesis (Hill-Reaction), resulting in bleaching and death within hours. 
Quinoclamine  was  evaluated  in  the  framework  of  Directive  91/414/EEC  with  Sweden  being  the 
designated rapporteur Member State (RMS). The representative use supported for the peer review 
process was a selective herbicide against common mosses in lawns and liverworts in ornamental pot 
plants (container plants). Following the peer review, which was carried out by EFSA, a decision on 
inclusion of the active substance in Annex I to Directive 91/414/EEC was published by means of 
Commission Directive 2008/66/EC
6, which entered into force on  01 January 2009.  According to 
                                                       
6 Commission Directive 2008/66/EC of 30 June 2008, OJ L 171, 1.7.2008, p. 9-15. Review of the existing MRLs for quinoclamine 
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Regulation (EU) No 540/2011
7, quinoclamine is deemed to have bee n approved under Regulation 
(EC) No 1107/2009
8. This approval is restricted to herbicide uses only. 
No  MRLs  are  currently  set  for quinoclamine; hence the default MRL of 0.01 mg/kg applies 
(according to art. 18, 1, b of Regulation (EC) No 396/2005). CXLs for quinoclamine are not available. 
Quinoclamine is only registered for use on non-consumable crops within the European Union  (turf, 
lawn, ornamentals and nursery stock plants) and the RMS did not report any  use authorised in third 
countries that might have a significant impact on international trade. 
ASSESSMENT 
Considering that the use of quinoclamine is only authorised on non-consumable crops within the EU 
(turf,  lawn,  ornamentals  and  nursery  stock  plants),  that  no  CXLs  are  available  for  this  active 
substance  and  that  no  uses  authorised  in  third  countries  were  notified  to  the  RMS,  European 
consumers are not expected to be exposed to residues of this active substance and a consumer risk 
assessment is, in principle, not required. Risk managers might have the interest, however, to enforce 
the potential illegal use of quinoclamine within the EU as well as the presence of illegitimate residue 
levels  in  imported  products.  In  order  to  assist  risk  managers  in  applying  the  most  appropriate 
enforcement measures, EFSA assessed the available data with particular attention for the analytical 
methods, the toxicological reference values and the nature of residues in plants and livestock. The 
assessment  of  EFSA  is  mainly  based  on  the  Draft  Assessment  Report  (DAR)  and  its  addendum 
prepared under Council Directive 91/414/EEC (Sweden, 2005, 2007), the evaluation report submitted 
by  the  RMS  (Sweden,  2010)  as  well  as  the  conclusion  on  the  peer  review  of  the  pesticide  risk 
assessment of the active substance quinoclamine (EFSA, 2007). 
1.  Methods of analysis 
No analytical method is required in products of plant and animal origin as the use of quinoclamine 
does not include applications on plants that are used as food or feed. Nevertheless, during the peer 
review under Directive 91/414/EC, a multi-residue method DFG S 19 using GC-ECD in grass was 
requested and evaluated due to the need for refinement of the risk assessment for grass-eating birds 
and mammals. It was mentioned as validated for determination of quinoclamine with an LOQ of 0.05 
mg/kg in grass. However, neither confirmatory nor ILV were available. Moreover, the conclusion was 
that the notifier was not able to explain the reason for the discrepancy in recoveries shown in the 
validation report and the residue study and this might need to be discussed (Sweden, 2005, 2007, 
2010; EFSA, 2007). 
2.  Mammalian toxicology 
The toxicological assessment of quinoclamine was peer reviewed under Directive 91/414/EEC and 
toxicological  reference  values  were  established  by  European  Commission  (EFSA,  2007b).  These 
toxicological reference values are summarized in Table 2-1. 
                                                       
7 Regulation (EU) No 540/2011 of 25 May 2011, OJ L 153, 11.6.2011, p. 1-186. 
8 Regulation (EC) No 1107/2009 of 21 October 2009, OJ 309, 24.11.2009, p. 1–50. Review of the existing MRLs for quinoclamine 
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Table 2-1:  Overview of the toxicological reference values 
  Source  Year  Value  Study relied upon  Safety 
factor 
Quinoclamine 
ADI  EFSA  2007b  0.002 mg/kg bw per d  2-year rat study  100 
ARfD  EFSA  2007b  0.05 mg/kg bw  28-day rat study  100 
 
3.  Residues 
In the framework of this review, residue data are in principle not required as the use of quinoclamine 
does not include applications on plants that are used as food or feed. Nevertheless, some data were 
provided under the peer review of Directive 91/414/EEC. 
Metabolism of quinoclamine was investigated for foliar application on leafy vegetable (grass) using 
[
14C-] labelled quinoclamine (Sweden, 2005). The characteristics of these studies are summarised in 
Table 3-1. 
Table 3-1:  Summary of available metabolism studies in plants 
Group  Crop  Label 
position 
Application and sampling details 
Method,  
F or G 
(a) 
Rate 
(kg a.s./ha) 
No  Sampling 
(DAT) 
Remarks 
Leafy 
vegetables  
Grass 
(different 
species and 
varieties) 
[
14C]-
Quinoclamine 
Spray 
application, 
G 
3.75  1  2, 7, 14 
and 28 
- 
(a):  Outdoor/field application (F) or glasshouse/protected/indoor application (G) 
 
Radiolabelled quinoclamine was applied at normal use rate. Total radioactive residues continuously 
decreased from 608 mg/kg fresh weight 2 days after application to 13 mg/kg fresh weight 28 days 
after application. Quinoclamine represented 94-63 % of the extractable radioactivity 14 days after 
application  and  28  %  at  the  last  sampling  (28  days  after  application).  The  remaining  extracted 
radioactivity  was  not  identified  but  consisted  of  different  polar  and  non  polar  compounds.  A 
metabolic pathway in plants can therefore not be determined. Nevertheless, the study showed that 
quinoclamine is the main constituent of the residue within 14 days after application and contribution 
of metabolites is minor within this time interval.  
Based on these data, EFSA is only able to conclude that it might be relevant to analyse for the parent 
compound quinoclamine in grass for enforcement of a potential illegal use. Data are however too 
limited to extrapolate these conclusions to any commodity of plant origin.  
EFSA also highlights that the uptake of quinoclamine residues in the potential following crops has not 
been investigated although the eventual conversion of turf, lawn, ornamental fields or nurseries to 
edible  plant  production  cannot  be  excluded.  Member  States  should  therefore  impose  adequate 
restrictions on the conversion of treated  turf, lawn, ornamental fields or nurseries to edible plant 
production.  Review of the existing MRLs for quinoclamine 
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4.  Consumer risk assessment 
A risk assessment is in principle not required considering that quinoclamine is only registered for use 
on non-consumable crops. In order to assess whether the default MRL of 0.01 mg/kg is sufficiently 
protective  for  European  consumers,  chronic  and  acute  intake  calculations  were  performed  using 
revision 2 of the EFSA PRIMo (EFSA, 2007a). 
The detailed results of the chronic intake calculations are reported in Appendix A to this document. 
The highest chronic exposure was calculated for UK infants, representing 33.9 % of the ADI, and the 
highest acute exposure was calculated for potatoes, representing 3.1 % of the ARfD. EFSA highlights 
that the above calculation does not reflect real exposure of consumers to quinoclamine residues; it is a 
theoretical calculation indicating that the default LOQ provides a satisfactory level of protection for 
the European consumer. 
CONCLUSIONS AND RECOMMENDATIONS 
The toxicological profile of quinoclamine was evaluated in the framework of Directive 91/414/EEC, 
which resulted in an ADI and an ARfD being established at 0.002 mg/kg bw per d and 0.05 mg/kg bw, 
respectively.  
Considering that the use of quinoclamine is restricted to non-consumable crops within the European 
Union, that no CXLs are available for this active substance and that no  uses authorised in third 
countries were notified to the RMS, residues of quinoclamine are not expected to occur in any plant 
or  animal  product.  However,  this  conclusion  is  only  valid  if  Member  States  impose  adequate 
restrictions on the conversion of treated  turf, lawn, ornamental fields or nurseries to edible plant 
production. 
Even though there are indications that the relevant residue following a foliar application in grass is the 
parent  compound  only,  EFSA  is  however  not  in  a  position  to  define  the  relevant  residue  for 
enforcement against the potential illegal use of quinoclamine. Validated analytical methods are also 
not available. 
A risk assessment is in principle not required considering that quinoclamine is only registered for use 
on non-consumable crops and that no import tolerances have been notified but the default MRL of 
0.01 mg/kg, as defined by Regulation (EC) No 396/2005, provides a satisfactory level of protection 
for the European consumer. 
Considering that the enforcement of potential illegal uses falls under the remit of risk managers, 
EFSA is not in a position to recommend whether the default MRL of 0.01 mg/kg, as defined by 
regulation (EC) No 396/2005, should apply or whether the setting of a specific LOQ is necessary. 
However, data for deriving a specific LOQ are very limited and quinoclamine is in any case not 
recommended for inclusion in Annex IV to the above regulation.  
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APPENDIX – PESTICIDE RESIDUES INTAKE MODEL (PRIMO) 
Status of the active substance: Included Code no.
LOQ (mg/kg bw): 0,01 proposed LOQ:
ADI (mg/kg bw/day): 0,002 ARfD (mg/kg bw): 0,05
Source of ADI: EFSA Source of ARfD: EFSA
Year of evaluation: 2007 Year of evaluation: 2007
5 34
No of diets exceeding ADI: ---
Highest calculated 
TMDI values in % 
of ADI  MS Diet
Highest contributor 
to MS diet 
(in % of ADI)
2nd contributor to 
MS diet 
(in % of ADI)
3rd contributor to 
MS diet 
(in % of ADI)
Commodity / 
group of commodities
pTMRLs at 
LOQ
(in % of ADI)
33,9 UK Infant  19,4 5,0 1,6 Potatoes 33,9
33,7 FR toddler 19,8 2,5 1,3 Apples 33,7
33,3 NL child 14,7 3,2 2,9 Potatoes 33,3
31,4 UK Toddler 11,4 10,3 2,0 Wheat 31,4
26,6 DE child 7,1 6,0 2,1 Wheat 26,6
23,5 WHO Cluster diet B  4,3 1,6 1,5 Tomatoes 23,5
22,2 FR infant 12,9 2,1 1,3 Carrots 22,2
20,3 DK child 6,3 2,8 2,2 Rye 20,3
18,8 IE adult 1,8 1,4 1,1 Maize 18,8
17,6 ES child 6,3 2,2 1,1 Oranges 17,6
16,2 SE  general population 90th percentile 6,2 2,1 1,6 Wheat 16,2
14,8 WHO cluster diet E 2,0 1,9 1,5 Milk and cream,  14,8
14,2 WHO cluster diet D 3,3 2,5 2,0 Potatoes 14,2
13,8 WHO regional European diet  2,4 2,0 1,5 Wheat 13,8
13,0 WHO Cluster diet F  2,0 1,8 1,7 Potatoes 13,0
11,3 NL general 3,3 1,4 1,0 Wheat 11,3
10,3 PT General population 2,7 2,0 1,2 Wine grapes 10,3
10,0 ES adult 2,5 1,2 0,6 Oranges 10,0
9,2 FR all population 2,0 1,6 1,3 Milk and cream,  9,2
8,9 UK vegetarian 1,9 1,6 1,0 Wheat 8,9
8,6 DK adult 2,7 1,0 0,7 Potatoes 8,6
8,2 IT kids/toddler 3,3 0,8 0,7 Tomatoes 8,2
8,1 UK Adult  2,0 1,5 0,8 Wheat 8,1
8,1 LT adult 2,0 1,6 0,9 Apples 8,1
7,1 FI  adult 2,8 0,6 0,5 Wheat 7,1
6,1 IT adult 2,1 0,6 0,4 Apples 6,1
4,9 PL  general population 1,7 1,0 0,4 Tomatoes 4,9
Milk and cream, 
Wheat
Potatoes Apples
Tomatoes
Other cereal
Milk and cream, 
Potatoes
Potatoes
Potatoes
Wheat
Potatoes
Wheat
Wheat
Wheat
Potatoes
Wheat
Milk and cream, 
Wheat
Potatoes
Potatoes
Sugar beet (root)
Potatoes
Apples
Milk and cream, 
Apples
Milk and cream, 
Commodity / 
group of commodities
Commodity / 
group of commodities
Milk and cream, 
Milk and cream, 
Quinoclamine
Toxicological end points
                     TMDI (range) in % of ADI
                        minimum - maximum
Chronic risk assessment - refined calculations
Conclusion:
The estimated Theoretical Maximum Daily Intakes (TMDI), based on pTMRLs were below the ADI. 
A long-term intake of residues of  Quinoclamine is unlikely to present a public health concern.
Milk and cream, 
Milk and cream, 
Sweet potatoes
Milk and cream, 
Milk and cream, 
Sugar beet (root)
Milk and cream, 
Wheat
Milk and cream, 
Milk and cream, 
Potatoes
Milk and cream, 
Milk and cream, 
Wheat
Wheat
Milk and cream, 
Milk and cream, 
Sugar beet (root)
Milk and cream, 
Milk and cream, 
Wheat
Wine grapes
Sugar beet (root)
Milk and cream, 
Wheat
 Review of the existing MRLs for quinoclamine 
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The acute risk assessment is based on the ARfD.
--- --- --- ---
IESTI 1 *) **) IESTI 2 *) **) IESTI 1 *) **) IESTI 2 *) **)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI  Commodities
pTMRL/ 
threshold MRL
(mg/kg)
3,1 Potatoes 0,01 / - 3,0 Melons 0,01 / - 1,1 Pumpkins 0,01 / - 1,1 Pumpkins 0,01 / -
3,0 Melons 0,01 / - 2,5 Milk and milk  0,01 / - 0,8 Watermelons 0,01 / - 0,8 Watermelons 0,01 / -
2,7 Oranges 0,01 / - 2,4 Watermelons 0,01 / - 0,8 Melons 0,01 / - 0,8 Melons 0,01 / -
2,5 Milk and milk  0,01 / - 2,2 Potatoes 0,01 / - 0,7 Chinese cabbage 0,01 / - 0,7 Chinese cabbage 0,01 / -
2,4 Watermelons 0,01 / - 2,0 Pineapples 0,01 / - 0,6 Cauliflower 0,01 / - 0,6 Cauliflower 0,01 / -
No of critical MRLs (IESTI 1) --- No of critical MRLs (IESTI 2) ---
--- ---
***) ***)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
Highest % of 
ARfD/ADI
Processed 
commodities
pTMRL/ 
threshold MRL
(mg/kg)
1,0 Apple juice 0,01 / - 0,2 Orange juice 0,01 / -
1,0 Orange juice 0,01 / - 0,1 Apple juice 0,01 / -
0,9 Carrot, juice 0,01 / - 0,1 Bread/pizza 0,01 / -
0,7 Grape juice 0,01 / - 0,1 Wine 0,01 / -
0,4 Peach juice 0,01 / - 0,1 Pineapples preserved 
with syrup
0,01 / -
For processed commodities, no exceedance of the ARfD/ADI was identified.
P
r
o
c
e
s
s
e
d
 
c
o
m
m
o
d
i
t
i
e
s
U
n
p
r
o
c
e
s
s
e
d
 
c
o
m
m
o
d
i
t
i
e
s
*) The results of the IESTI calculations are reported for at least 5 commodities. If the ARfD is exceeded for more than 5 commodities, all IESTI values > 90% of ARfD are reported. 
**) pTMRL: provisional temporary MRL
***) pTMRL: provisional temporary MRL for unprocessed commodity
No exceedance of the ARfD/ADI was identified for any unprocessed commodity. 
 
Acute risk assessment /children - refined calculations Acute risk assessment / adults / general population - refined calculations
Conclusion:
For Quinoclamine IESTI 1 and IESTI 2 were calculated for food commodities for which pTMRLs were submitted and for which consumption data are available.
In the IESTI 1 calculation, the variability factors were 10, 7 or 5 (according to JMPR manual 2002), for lettuce a variability factor of 5 was used. 
In the IESTI 2 calculations, the variability factors of 10 and 7 were replaced by 5. For lettuce the calculation was performed with a variabilty factor of 3.  
No of commodities for which ARfD/ADI is 
exceeded (IESTI 2):
For each commodity the calculation is based on the highest reported MS consumption per kg bw and the corresponding unit weight from the MS with the critical consumption. If no data on the unit weight was available from that MS an average 
European unit weight was used for the IESTI calculation. 
No of commodities for which 
ARfD/ADI is exceeded:
No of commodities for which ARfD/ADI 
is exceeded:
Threshold MRL is the  calculated residue level which would leads to an exposure equivalent to 100 % of the ARfD.  
No of commodities for which ARfD/ADI 
is exceeded (IESTI 1):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 2):
No of commodities for which 
ARfD/ADI is exceeded (IESTI 1):
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ABBREVIATIONS 
a.s.  active substance 
ADI  acceptable daily intake 
ARfD  acute reference dose 
bw  body weight 
CXL  codex maximum residue limit 
d  day 
DAR  Draft Assessment Report (prepared under Council Directive 91/414/EEC) 
DAT  days after treatment 
EC  European Commission 
EFSA  European Food Safety Authority 
EU  European Union 
GAP  good agricultural practice 
GC-ECD  gas chromatography with electron capture detector 
ha  hectare 
ILV  independent laboratory validation 
ISO  International Organization for Standardization 
IUPAC  International Union of Pure and Applied Chemistry 
LOQ  limit of quantification  
MRL  maximum residue limit 
MS  Member States 
PHI  pre-harvest interval 
PRIMo  (EFSA) Pesticide Residues Intake Model 
PROFile  (EFSA) Pesticide Residues Overview File 
RA  risk assessment 
RD  residue definition 
RMS  rapporteur Member State 
 